Study Published in Nature Digital Medicine Shows Potential of Machine Learning and Augmented Reality-based Digital Biomarkers in Alzheimer’s Detection


We are actively supporting global clinical trials, the clinical research of our investigational platform and we are leading several academic collaborations in centers of excellence for clinical research.

We are open to hearing from biotech and pharmaceutical companies who may be interested in incorporating our investigational platform into CNS clinical trials for further clinical exploration.

Our platform is currently intended for investigational use only. The platform has not received FDA clearance or approval and is not available for commercial sale.